DEC 03, 2015 9:59 AM PST

Inflammatory Molecules Linked to Rare Bone Growth Disease

WRITTEN BY: Kara Marker
Fibrodysplasia ossificans progressiva (FOP) is an extremely rare genetic disease that causes bone to grow in abnormal areas like ligaments, tendons, and skeletal muscles. This atypical growth causes soft tissues to "undergo a metamorphosis" transforming normally flexible tissues into hard bone, "locking joints in place and making movement impossible" (National Organization for Rare Disorders).

In the past, treatment for this debilitating disorder included targeting the signaling pathway of bone morphogenetic proteins (BMPs), since the hyperactivity of these multi-functional growth factors is the root cause of FOP (NIH). However, in a new study published in PNASscientists from the Center for iPS Cell Research and Application (CiRA) at Kyoto University utilized the ability of induced pluripotent stem cells (iPSCs) to reprogram diseased cells in FOP patients. 
FOP in a mouse model: abnormal bone growth is circled

iPSCs are listed by the NIH as "adult cells that have been genetically reprogrammed to an embryonic stem cell–like state," meaning they are essentially identical donor cells that can be induced to differentiate differently, making them useful by scientists to repair diseased tissues. 

People with the genetic mutation for FOP develop symptoms of the disease after experiencing inflammation or trauma. The team from CiRA aimed to utilize the reprogrammable iPSCs in FOP mouse models to identify a certain inflammatory molecule triggering FOP development and potentially reverse its effect.

Studying alternative treatments to BMP signaling drug targets introduces an entirely new perspective on FOP treatment. CiRA scientists believed that the abnormality of BMP signaling causing FOP could be either unconditional BMP activation or atypically enhanced signaling strength when BMP is activated. Looking closer at the cause of FOP BMP signaling, they identified the role of Activin-A, a member of the transforming growth factor-beta superfamily, in the onset of FOP (NIH). 

“Using iPS cell technology, the scientists found that only cells harboring the FOP gene mutation would respond to Activin-A by significantly increasing their BMP signaling," a report from Kyoto University stated. 

Since immune actions in response to trauma trigger FOP, the treatment and study of FOP has historically been very complicated, seeing as surgical treatments to remove excessive bone only stimulate more irregular bone growth. The discovery of Activin-A's connection to BMP signaling offers a new method for repressing diseased bone growth in FOP patients and lends new information to the realm of drug discovery and bone growth in general. 

Watch the following video to learn more about the clinical application potential of iPSCs.


Source: Kyoto University 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 30, 2020
Drug Discovery & Development
APR 30, 2020
Researchers Use AI to Accelerate COVID-19 Drug Development
Researchers from the National University of Singapore (NUS) have developed an artificial intelligence platform to accele ...
MAY 04, 2020
Cancer
MAY 04, 2020
A Retroactive Study Finds an Immunotherapy Effective as a Third-Line Therapy
Cancer is a particularly persistent disease. Many therapies are composed of one or more different treatments. These trea ...
MAY 08, 2020
Immunology
MAY 08, 2020
Vaccine Prevents Virally-induced Type 1 Diabetes
Scientists aren’t exactly sure what causes type 1 diabetes, although genetics and environmental factors are presum ...
MAY 16, 2020
Cancer
MAY 16, 2020
Red Blood Cells: More than just an Oxygen Delivery Service
The human body is a complex network of systems that often interact and affect each other. Recent work shows that red blo ...
MAY 29, 2020
Cannabis Sciences
MAY 29, 2020
Japanese Company Makes CBD from Orange Peels
Japanese company, Hiro International, has derived cannabidiol (CBD) oil from orange peels. Free from tetrahydrocannabino ...
MAY 29, 2020
Genetics & Genomics
MAY 29, 2020
Advances in Our Understanding of Huntington's Disease
Huntington's disease (HD) is a fatal neurodegenerative disease caused by an expanded sequence in the huntingtin gene.
Loading Comments...